The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Germany

Robin Köck1, Alexander Mellmann, Frieder Schaumburg

  • 1Institut für Hygiene, Universitätsklinikum Münster, Germany. robin.koeck@ukmuenster.de

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is a growing concern in Germany, with new sources emerging beyond healthcare settings. Preventing MRSA spread requires addressing these evolving challenges in hospitals, communities, and animal reservoirs.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) has historically been prevalent in healthcare settings (HA-MRSA).
  • Since the late 1990s, community-associated MRSA (CA-MRSA) infections have increased globally.
  • Animal reservoirs are recognized as significant sources for human MRSA acquisition.

Purpose of the Study:

  • To review the current epidemiological situation of MRSA in Germany.
  • To identify the evolving sources and transmission routes of MRSA.

Main Methods:

  • A selective PubMed search of articles published up to 2010.
  • Inclusion of publications from national reference institutions up to 2010.

Main Results:

  • Approximately 132,000 MRSA cases occur annually in German hospitals.
  • MRSA is detected in 18-20% of inpatient S. aureus cultures.
  • CA-MRSA is not yet endemic in Germany, with risk factors including travel and close contact.
  • Agricultural livestock represent the primary animal reservoir, with zoonotic transmission to humans.
  • Both CA-MRSA and animal-associated MRSA can lead to nosocomial infections.

Conclusions:

  • MRSA reservoirs have expanded beyond traditional healthcare facilities.
  • New strategies are needed to combat the spread of MRSA from emerging sources.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mismatch Repair01:36

Mismatch Repair

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...